Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2011 / Cilt: 45 - Sayı: 1

Henoch-schönlein purpura after H1N1 vaccination

H1N1 aşısı sonrası Henoch-schönlein purpurası

Pages
46–48
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

With the increasing use of Influenza vaccination, attention should be drawn to the potential serious side effects as Henoch-Schönlein purpura.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Influenza vaccination is a widely accepted practice, particularly during pandemics.
📊
Key Findings & Data:Herein, we describe a patient who presented with Henoch-Schönlein purpura following Influenza A (H1N1) vaccination.
💡
Conclusion & Impact:With the increasing use of Influenza vaccination, attention should be drawn to the potential serious side effects as Henoch-Schönlein purpura.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Influenza vaccination is a widely accepted practice, particularly during pandemics. The side effects of influenza vaccine are usually mild and consist of local reactions and constitutional symptoms. Rarely, serious adverse effects may be encountered. Herein, we describe a patient who presented with Henoch-Schönlein purpura following Influenza A (H1N1) vaccination. With the increasing use of Influenza vaccination, attention should be drawn to the potential serious side effects as Henoch-Schönlein purpura.

Özet

İnfluenza aşılaması, özellikle pandemiler sırasında, giderek daha sık yapılan bir uygulama haline gelmektedir. Bu aşılara ait yan etkiler genellikle hafif şiddette olup, lokal reaksiyonlar ve konstitüsyonel semptomlar şeklindedir. Nadiren ciddi yan etkiler de görülebilmektedir. Bu yayında İnfluenza A (H1N1) aşılaması sonrası Henoch-Schönlein purpurası gelişen bir olgu sunulmuştur. İnfluenza aşılarının giderek artan kullanımıyla, Henoch-Schönlein purpurası gibi ciddi yan etkilerin görülebileceği hatırdatutulmalıdır.

🔖

Cite This Article

ARICA, A. D., DERECİ, S., SARAL, Y., ÖZKASAP, S., YAYLI, S., ARICA, İ. E., ERSÖZ, Ş. (2022). Henoch-schönlein purpura after H1N1 vaccination. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 45 - Sayı: 1, 46–48. https://ajindex.com/articles/621997

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practice (ACIP). MMWR Morb Mortal Wkly Rep 2004;53:1-40
  2. Ulm S, Hummel M, Emig M, et al.: Leukocytoclastic vasculitis and acute renal failure after ‹nfluenza vaccination in an elderly patient with myelodysplastic syndrome. Onkologie 2006;29:470-2
  3. Famularo G, Nicotra GC, Minisola G, De Simone C: Leukocytoclastic vasculitis after ‹nfluenza vaccination. J Clin Rheumatol 2006;12:48-50
  4. Hyla-Klekot L, Kucharska G, Cieslak W: Necrotizing glomerulonephritis in decursu vasculitis after vaccination against ‹nfluenza. Pol Merkuriusz Lekarski 2005;19:75-7
  5. Uji M, Matsushita H, Iwata S: Microscopic polyangiitis after ‹nfluenza vaccination. Intern Med 2005;44:892-6
  6. Hull JH, Mead SH, Foster OJ, Modarres-Sadeghi H: Severe vasculitic neuropathy following ‹nfluenza vaccination. J Neurol Neurosurg Psychiatry 2004;75:1507-8
  7. Walker SL, Swindells KJ, Chalmers RJ: Leucocytoclastic vasculitis and ‹nfluenza immunization. Clin Exp Dermatol 2004;29:95-6
  8. Tavadia S, Drummond A, Evans CD, Wainwright NJ. Leucocytoclastic vasculitis and ‹nfluenza vaccination. Clin Exp Dermatol 2003;28:154-6
  9. Lyngkaran P, Limaye V, Hill C, Henderson D, Pile KD, Rischmueller M. Rheumatoid vasculitis following ‹nfluenza vaccination. Rheumatology (Oxford) 2003;42:907-9
  10. Ritter O, Bonz A, Strotmann J, Langenfeld H: Myocardial infarction after ‹nfluenza vaccination. Z Kardiol 2003;92:962-5
  11. Yanai-Berar N, Ben Itzhak O, Gree J, Nakhoul F: Influenza vaccination induced leukocytoclastic vasculitis and pauci-immune crescentic glomerulonephritis. Clin Nephrol 2002;58:220-3
  12. Saadoun D, Cacoub P, Mahoux D, Sbai A, Piette JC: Postvaccine vasculitis: a report of three cases. Rev Med Interne 2001;22:172-6
  13. Watanabe T, Onda H: Henoch-Schonlein purpura with antiphospholipid antibodies following an ‹nfluenza vaccination. Pediatr Nephrol 2001;16:458-9
  14. Perez C, Loza E, Tinture T. Giant cell arteritis after ‹nfluenza vaccination. Arch Intern Med 2000;160:2677
  15. Kelsall JT, Chalmers A, Sherlock CH, Tron VA, Kelsall AC: Microscopic polyangitis after ‹nfluenza vaccination. J Rheumatol 1997;24:1198-202
  16. Gavaghan T: Severe systemic vasculitic syndrome post ‹nfluenza vaccination. Aust NZ J Med 1993;23:220
  17. Mader R, Narendran A, Lewtas J, et al.: Systemic vasculitis following ‹nfluenza vaccination: report of 3 cases and literature re